Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
Slika profila

Marko Lucijanic

34166

Marko

Lucijanic

dr. sc.

-347024

nije evidentirano
Naziv Akcije
Lucijanić, Marko; Krečak, Ivan; Bušić, Iva; Atić, Armin; Stojić, Josip; Sabljić, Anica; Sorić, Ena; Veić, Petra; Marević, Sanja; Derek, Lovorka et al. Estimated plasma volume status in COVID-19 patients and its relation to comorbidities and clinical outcomes // Journal of thrombosis and thrombolysis, (2023),
Piskač Živković, Nevenka; Mutvar, Andreja; Kušter, Dinka; Lucijanić, Marko; Ljilja Posavec, Anja; Kučić Cvetković, Daria; Lalić, Kristina; Vergles, Mirna; Udovičić, Mario; Baršić, Bruno et al. Longitudinal analysis of chest Q-SPECT/CT in patients with severe COVID-19 // Respiratory medicine, (2023), doi: 10.1016/j.rmed.2023.107461
Lucijanić, Marko ; Krečak, Ivan ; Sorić, Ena ; Galušić, Davor ; Holik, Hrvoje ; Periša, Vlatka ; Morić Perić, Martina ; Zekanović, Ivan ; Kušec, Rajko Palpable spleen size is differently prognostic in primary and secondary myelofibrosis // Leukemia & lymphoma, 64 (2023), 4; 893-896. doi: 10.1080/10428194.2023.2179360
Lucijanic, Marko; Tjesic-Drinkovic, Ida; Piskac Zivkovic, Nevenka; Pastrovic, Frane; Rob, Zrinka; Bacevac, Mersiha; Sedinic Lacko, Martina,; Dzambas, Eleonora; Medic, Barbara; Vukoja, Ivan et al. Incidence, Risk Factors and Mortality Associated with Major Bleeding Events in Hospitalized COVID-19 Patients // Life, 13 (2023), 8; 1699-1711. doi: https://doi.org/10.3390/life13081699
Salai, Grgur ; Vrazic, Hrvoje ; Kovacevic, Ivona ; Janes, Linda Malnar ; Marasovic, Ivan ; Ranilovic, Darjan ; Vukoja, Damir ; Zelenika Margeta, Marina ; Huljev–Sipos, Ivana ; Lalic, Kristina et al. Investigating the role of obstructive pulmonary diseases and eosinophil count at admission on all- cause mortality in SARS-CoV-2 patients // Wiener klinische Wochenschrift, (2023), 2023 Apr 24; 1-9. doi: 10.1007/s00508-023-02180-w
Lucijanić, Marko ; Živković, Nevenka Piskač ; Režić, Tanja ; Durlen, Ivan ; Stojić, Josip ; Jurin, Ivana ; Šakota, Sara ; Filipović, Dora ; Kurjaković, Iva ; Jordan, Ana et al. The performance of the WHO COVID-19 severity classification, COVID-GRAM, VACO Index, 4C Mortality, and CURB-65 prognostic scores in hospitalized COVID-19 patients: data on 4014 patients from a tertiary center registry // Croatian medical journal, 64 (2023), 1; 13-20. doi: 10.3325/cmj.2023.64.13
Lucijanic, Marko ; Krecak, Ivan ; Soric, Ena ; Sabljic, Anica ; Galusic, Davor ; Holik, Hrvoje ; Perisa, Vlatka ; Peric, Martina Moric ; Zekanovic, Ivan ; Kusec, Rajko Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis // Biochemia medica, 33 (2023), 2; 020901, 8. doi: 10.11613/bm.2023.020901
Krečak, Ivan ; Čeko, Monika ; Nižetić, Karla ; Čubrić, Eva ; Županović, Mediana ; Skelin, Marko ; Lucijanić, Marko Hematocrit to hemoglobin ratio (HHR) may improve prognostication in patients with pulmonary embolism // Scandinavian journal of clinical & laboratory investigation, 83 (2023), 3; 200-203. doi: 10.1080/00365513.2023.2191334
Lucijanic, Marko ; Bistrovic, Petra ; Jordan, Ana ; Mihaljevic, Iva ; Bukvic, Stela ; Kovacevic, Stjepan ; Ranilovic, Darjan ; Sakota, Sara ; Vlasac Glasnovic, Josipa ; Delic-Brkljacic, Diana Remdesivir use in severe and critical COVID-19 patients might be associated with lower incidence of arterial thrombotic events // American journal of emergency medicine, 70 (2023), 41-45. doi: 10.1016/j.ajem.2023.05.007
Lucijanic, Marko ; Krecak, Ivan Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms // Journal of thrombosis and thrombolysis, 55 (2023), 4; 760-761. doi: 10.1007/s11239-023-02779-w
nije evidentirano
nije evidentirano